These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 2522076)

  • 1. [Local thrombolysis in peripheral arterial occlusion].
    Hess H
    Herz; 1989 Feb; 14(1):12-21. PubMed ID: 2522076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Local lysis therapy in acute arterial thrombosis].
    Roth FJ; Rieser R; Scheffler A
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():427-34. PubMed ID: 1983584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LYS-plasminogen shortens the duration of local thrombolytic treatment of peripheral arterial occlusions--a randomized controlled trial.
    Poredos P; Videcnik V
    Wien Klin Wochenschr; 1999 Jan; 111(1):21-5. PubMed ID: 10067266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catheter-directed thrombolysis for acute limb ischemia caused by native artery occlusion: an experience of a university hospital.
    Wongwanit C; Hahtapornsawan S; Chinsakchai K; Sermsathanasawadi N; Hongku K; Ruangsetakit C; Mutirangura P
    J Med Assoc Thai; 2013 Jun; 96(6):661-8. PubMed ID: 23951822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [rt-PA in extracardiac thromboembolic vascular occlusions].
    Cortellaro M; Cofrancesco E; Polli EE
    Ann Ital Med Int; 1990; 5(1):61-9. PubMed ID: 2119673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technique and results of "low-dose" infusion.
    Katzen BT
    Cardiovasc Intervent Radiol; 1988; 11 Suppl():S41-7. PubMed ID: 3131007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombolytic and haemorrhagic effects of bolus doses of tissue-type plasminogen activator and a hybrid plasminogen activator with prolonged plasma half-life (K2tu-PA: CGP 42935).
    Agnelli G; Pascucci C; Nenci GG; Mele A; Bürgi R; Heim J
    Thromb Haemost; 1993 Aug; 70(2):294-300. PubMed ID: 8236138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinolysis with rt-PA in peripheral arterial occlusions].
    Hess H; Mietaschk A; Becker-Lienau C
    Klin Wochenschr; 1988; 66 Suppl 12():135-6. PubMed ID: 3126341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrinolytic profiles in local low-dose thrombolysis with streptokinase and recombinant tissue plasminogen activator.
    Berridge DC; Earnshaw JJ; Westby JC; Makin GS; Hopkinson BR
    Thromb Haemost; 1989 Apr; 61(2):275-8. PubMed ID: 2501898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Local intra-arterial thrombolysis in acute ischemia of an extremity].
    Enevoldsen MT; Rørdam P; Schroeder TV
    Ugeskr Laeger; 1996 Sep; 158(36):5011-4. PubMed ID: 8928238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Local low dosage thrombolysis with rt-PA. Systemic effects on the fibrinolytic system--data on the assessment of the value and risk of this method].
    von Bilderling P; Spannagl M; Mietaschk A; Iven M; Schramm W; Hess H
    Vasa Suppl; 1991; 33():132-3. PubMed ID: 1788645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Thrombotic and thromboembolic occlusions of leg arteries and bypasses. Short-term versus long-term lysis].
    Zwaan M; Rinast E; Kummer-Kloess D; Weiss HD; Gmelin E
    Rofo; 1993 Jun; 158(6):536-41. PubMed ID: 8507844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Turbulent axially directed flow of plasma containing rt-PA promotes thrombolysis of non-occlusive whole blood clots in vitro.
    Tratar G; Blinc A; Strukelj M; Mikac U; Sersa I
    Thromb Haemost; 2004 Mar; 91(3):487-96. PubMed ID: 14983224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic treatment of acute pulmonary embolism.
    Charbonnier B; Meyer G; Stern M; Sors H; Brochier ML
    Herz; 1989 Jun; 14(3):157-71. PubMed ID: 2500388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of plasminogen activator inhibitor-1 levels following thrombolytic therapy with rt-PA as compared to streptokinase and patency of infarct related coronary artery.
    Paganelli F; Alessi MC; Morange P; Maixent JM; Lévy S; Vague IJ
    Thromb Haemost; 1999 Jul; 82(1):104-8. PubMed ID: 10456462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of the use of the thromboxane A2 antagonist, sulotroban, in combination with streptokinase for local thrombolysis in patients with recent peripheral arterial occlusions: clinical effects, platelet function and fibrinolytic parameters.
    Lonsdale RJ; Heptinstall S; Westby JC; Berridge DC; Wenham PW; Hopkinson BR; Makin GS
    Thromb Haemost; 1993 Feb; 69(2):103-11, 123. PubMed ID: 8456421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thrombolytic therapy for arterial occlusion: a mixed blessing.
    Smith CM; Yellin AE; Weaver FA; Li KM; Siegel AE
    Am Surg; 1994 May; 60(5):371-5. PubMed ID: 8161090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: a randomized trial.
    Meyerovitz MF; Goldhaber SZ; Reagan K; Polak JF; Kandarpa K; Grassi CJ; Donovan BC; Bettmann MA; Harrington DP
    Radiology; 1990 Apr; 175(1):75-8. PubMed ID: 2107563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.